3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
2
Unknown
1
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Motor Activity
35
Breast Neoplasms
19
Neoplasms
18
Fatigue
9
Prostatic Neoplasms
4
Lung Neoplasms
4
Hematologic Neoplasms
4
Colorectal Neoplasms
4
Obesity
3
Weight Loss
2
Smoking
2
Sedentary Behavior
2
Postoperative Complications
2
Ovarian Neoplasms
2
Multiple Myeloma
2
Mixed Cancer
2
Lymphedema
2
Frailty
2
Colonic Neoplasms
2
Cardiotoxicity
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Urologic Neoplasms
1
Urinary Incontinence
1
Stomach Neoplasms
1
Sarcoma
1
Risk Reduction Behavior
1
Interventions
Fluorouracil
19
Oxaliplatin
17
Capecitabine
16
Leucovorin
14
Cisplatin
12
Irinotecan
11
Gemcitabine
11
Drug Therapy
11
Bevacizumab
10
Radiosurgery
9
Cetuximab
9
pembrolizumab
8
Docetaxel
8
Everolimus
7
spartalizumab
6
Sunitinib
6
Radiotherapy
6
Paclitaxel
6
Neoadjuvant Therapy
6
Trastuzumab
5
S 1 (combination)
5
Nivolumab
5
Immunotherapy
5
Immune Checkpoint Inhibitors
5
Cyclophosphamide
5
Chemotherapy, Adjuvant
5
Carboplatin
5
palbociclib
4
manganese chloride
4
Surgical Procedures, Operative
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Neoplasm Metastasis
×
Exercise
×
Clear all
NCT02162914
2020-07-31
REACHIN
Erasme University Hospital
Phase 2
Unknown
66 enrolled